Ebola
4Curable or preventable in mostAI-generated
Burden-over-time charts — how many people this disease affects and whether that number is rising or falling — are coming to this page. The treatability read, milestones, and live trial pipeline below are current.
Milestones
dot size = significance- 2019Vesicular stomatitis virus encoding ebola virus glycoprotein approved (FDA)
- 2020Maftivimab approved (FDA)
- 2020Odesivimab approved (FDA)
- 2020Atoltivimab approved (FDA)
- 2020Adenovirus type 26 encoding ebola virus glycoprotein approved (FDA)
- 2020Vaccinia virus, modified encoding ebola virus glycoprotein and nucleoprotein approved (FDA)
- 2020Ansuvimab approved (FDA)
What's being tested now
Trials started per year, stacked by phase (darker = later phase). Source: ClinicalTrials.gov via Clin2, which tracks studies recruiting in recent years — early years undercount.
See all 7 active Ebola Virus Disease trials on Clin2 →